167 results
S-8
EX-99.1
NGNE
Neurogene Inc
20 Feb 24
Registration of securities for employees
4:16pm
this Plan unless arising out of such person’s own fraud or bad faith.
10.8 Lock-Up Period. Participants shall not offer, pledge, sell, contract to sell
S-8
EX-99.2
11nux2
20 Feb 24
Registration of securities for employees
4:16pm
8-K
EX-10.20
0nt9w54xji9ufy6mx hv
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
8-K
EX-10.27
38hc1f7kx0i85d1
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
8-K
EX-10.21
yghp4
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
8-K
EX-3.3
ip9bp611t1mue09au
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
S-4/A
fobeq8g
28 Sep 23
Registration of securities issued in business combination transactions (amended)
4:28pm
S-4/A
EX-10.31
k9lc8
28 Sep 23
Registration of securities issued in business combination transactions (amended)
4:28pm
S-4/A
EX-10.29
xaqpmqpeq0aa h3b42p
28 Sep 23
Registration of securities issued in business combination transactions (amended)
4:28pm
S-4/A
EX-10.30
mo0u ej7r5eh7
28 Sep 23
Registration of securities issued in business combination transactions (amended)
4:28pm